3200 Lakeside Dr.
Santa Clara
CA
95054
USA
(408) 845-3000
Related Content
October 18, 2011 — Abbott announced the investigational Absorb bioresorbable vascular scaffold (BVS) has been recognized ...
October 18, 2011
Feature | Dave Fornell
The Holy Grail sought for more than two decades by interventional cardiology has been proof that minimally invasive ...
October 11, 2011
October 4, 2011 – Abbott today said it began enrolling U.S. patients in the EXCEL (Evaluation of Xience Prime or Xience ...
October 04, 2011
Feature | Dave Fornell
There have been several key news items from the U.S. stent market over the past year. These include the introduction of ...
September 26, 2011
Feature | Kamran Zamanian, Ph.D., and Jamie Stillborn, iData Research Inc.
For decades, stents have been used in coronary and peripheral procedures in Europe and the United States to prevent or ...
September 21, 2011
September 8, 2011 – Abbott announced the initiation of ABSORB BTK, an international clinical trial evaluating the safety ...
September 08, 2011
August 31, 2011 — Results of a recent randomized controlled study show the drug-eluting stent Xience V performs well in ...
August 31, 2011
August 29, 2011 — An observational study demonstrates the percutaneous catheter-based MitraClip treatment improves ...
August 29, 2011
August 17, 2011 – Abbott announced today that the first patient in Japan has been treated with the Absorb bioresorbable ...
August 17, 2011
August 10, 2011 – The U.S. Food and Drug Administration (FDA) has approved Abbott’s RX Herculink Elite Renal Stent ...
August 10, 2011© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now